InsiderClue
← All stocks

abrdn Life Sciences Investors

HQL Net selling
CIK 0000884121 #5708 in the set updated 18 Sep 2026
Bought (12 mo)
$144.25K
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$1.25M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$1.25M
3 of 3 sales
Net
−$1.11M
−$1.11M against sales at will

By person

3 insiders · 5 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Saba Capital Management, L.P. entity
10% owner
—
$1.25M (3)
−$1.25M
2,837,633
$56.53M
−17.3%
Pittard Christian
Director
$133.75K (1)
—
+$133.75K
7,923
$157.83K
—
Mahai Chris LaVictoire
Director
$10.50K (1)
—
+$10.50K
527
$10.50K
—

No percentages here. abrdn Life Sciences Investors reports its share count only per share class, which the XBRL frames API does not carry.

Individual transactions

5
Insider
Date
Role
Action
Shares
Price
Amount
Mahai Chris LaVictoire
16 Jul 2026
Director
Buy
527
$19.92
$10.50K
Pittard Christian
16 Dec 2025
Director
Buy
7,923
$16.88
$133.75K
Saba Capital Management, L.P.
22 Sep 2025
10% owner
Sell indirect
41,623
$14.14
$588.55K
Saba Capital Management, L.P.
19 Sep 2025
10% owner
Sell indirect
6,989
$14.10
$98.54K
Saba Capital Management, L.P.
18 Sep 2025
10% owner
Sell indirect
40,208
$14.07
$565.73K

What was left out

Form 4 filings counted 4
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 0
History held since 29 Jan 2018